Search Results
Jan 19, 2026, 03:00 ET H.I.G. Realty et le Barts Health NHS Trust s'associent pour lancer le premier projet de Barts dédié aux sciences de la vie
parcours allant du prototype au patient et renforcera la capacité d'innovation du Royaume-Uni par l'intermédiaire du NHS. Shane DeGaris, directeur général du Barts Health NHS Trust, a déclaré : « Grâce au Barts Life Sciences Cluster, nous réunissons les cliniciens, les patients, ainsi que les
More news about: H.I.G. Capital
Jan 19, 2026, 02:00 ET LifeArc and Global Alzheimer's Platform Foundation - Scientists test whether a finger prick blood test could be used to help diagnose Alzheimer's disease before symptoms begin
of new treatments and develop simple and cost-effective tests."Further evidence is still needed before a blood test can be introduced into the NHS, but the Bio-Hermes-002 study aims to validate, in a large-scale, internationally diverse population, this new finger prick-based approach.It's
More news about: LifeArc
Jan 15, 2026, 10:30 ET Global Digital Immunoassays Market to Hit USD 7.1 Billion by 2036; High Demand for Ultra-High Sensitivity Testing Drives 11.4% CAGR
the U.S. remains a benchmark for digital integration and LIS-compatible diagnostic workflows.United Kingdom (10.0% CAGR): The push for NHS efficiency and automation to reduce manual handling is driving steady adoption across the U.K.'s major healthcare clusters.Overcoming
More news about: Future Market Insights
Jan 15, 2026, 06:01 ET First Patients in the UK Receive Doses of Blue Earth Therapeutics' Investigational Radiopharmaceutical Therapy Lutetium (177Lu) rhPSMA-10.1 Injection for Metastatic Castrate Resistant Prostate Cancer
Cook Cancer Institute pride ourselves on bringing studies like this to our Teesside patients and we are pleased to be working with colleagues at other NHS trusts and the radiopharmaceutical industry to support the generation of high-quality clinical data for patients with advanced prostate cancer."The
More news about: Blue Earth Therapeutics Limited
Jan 14, 2026, 08:00 ET RLDatix Appoints Richard Jarvis as Chief Technology Officer
Health, part of Optum, where he led large-scale engineering and analytics teams supporting digital infrastructure for primary care and pharmacy across the NHS. Previously, as Chief Analytics Officer, he built and launched EMIS-X Analytics, one of the UK's largest cloud-based healthcare data environments, enabling
More news about: RLDatix
Jan 14, 2026, 08:00 ET RLDatix Appoints Richard Jarvis as Chief Technology Officer
Health, part of Optum, where he led large-scale engineering and analytics teams supporting digital infrastructure for primary care and pharmacy across the NHS. Previously, as Chief Analytics Officer, he built and launched EMIS-X Analytics, one of the UK's largest cloud-based healthcare data environments, enabling
More news about: RLDatix
Jan 14, 2026, 08:00 ET Strong Q3 Performance: Sequential Revenue Growth of 0.6% in CC, Large Deal Wins of $4.8 billion
aviation."Infosys announced its collaboration with NHS Business Services Authority (NHSBSA) to deliver a new workforce management solution for NHS in England and Wales. Michael Brodie, Chief Executive, NHSBSA, said, "Delivering the Future NHS Workforce Solution is a critical step in supporting
More news about: Infosys
Jan 14, 2026, 07:55 ET Strong Q3 Performance: Sequential Revenue Growth of 0.6% in CC, Large Deal Wins of $4.8 billion
aviation."Infosys announced its collaboration with NHS Business Services Authority (NHSBSA) to deliver a new workforce management solution for NHS in England and Wales. Michael Brodie, Chief Executive, NHSBSA, said, "Delivering the Future NHS Workforce Solution is a critical step in supporting
More news about: Infosys
Jan 13, 2026, 18:16 ET MediDrive™ Invests in SPRYT to Advance AI-Driven Care Access and Transform the Patient Experience
to." Global Momentum Backed by Proven Results Asa has delivered significant impact across the seven National Health Service (NHS) regions of England, improving attendance by more than 160 percent. SPRYT is currently deploying its technology across major US health systems, with
More news about: MediDrive
Jan 09, 2026, 12:40 ET M&G champions UK innovation in drug discovery by leading US$50 million funding round for biotech company bit.bio
health policy, and governance for more than two decades with distinguished leadership roles, including Chair of the NHS England Board, Chair of University College London Hospitals NHS Foundation Trust, Parliamentary Under-Secretary of State at the Department of Health, and Member of Parliament and long-standing
More news about: bit.bio; M&G Investments
Jan 09, 2026, 12:31 ET M&G champions UK innovation in drug discovery by leading US$50 million funding round for biotech company bit.bio
health policy, and governance for more than two decades with distinguished leadership roles, including Chair of the NHS England Board, Chair of University College London Hospitals NHS Foundation Trust, Parliamentary Under-Secretary of State at the Department of Health, and Member of Parliament and long-standing
More news about: bit.bio; M&G Investments
Jan 08, 2026, 08:21 ET Registration Is Now Open for NHS Concept to Commerce, the Retail Industry's Premier Product Discovery & Sourcing Event
access.NHS Concept to Commerce Networking Party at Atomic Golf (March 31): An energetic evening of networking, food and drinks, and interactive golf games in an unforgettable, immersive setting just off the Las Vegas Strip. (Party ticket required)"NHS Concept to Commerce
More news about: NHS Concept to Commerce
Dec 31, 2025, 16:30 ET NEUBERGER HIGH YIELD STRATEGIES FUND ANNOUNCES MONTHLY DISTRIBUTION
NEW YORK, Dec. 31, 2025 /PRNewswire/ -- Neuberger High Yield Strategies Fund Inc. (NYSE American: NHS) (the "Fund") has announced a distribution declaration of $0.0905 per share of common stock. The distribution announced today is payable on January
More news about: Neuberger Berman
Dec 22, 2025, 08:00 ET Innovative Eyewear, Inc. Announces Participation in Key Industry Events in Q1 2026
https://www.visionexpo.com/en-us.htmlNHS Concept to Commerce (Las Vegas, NV; March 30 – April 2): The premier event that connects retailers, manufacturers, wholesalers, and distributors
More news about: Innovative Eyewear, Inc.
Dec 17, 2025, 09:00 ET Ultromics Secures Strategic Investment from the American Heart Association's Go Red for Women Venture Fund™
Ultromics is redefining cardiovascular care with FDA-cleared, AI-powered tools that enhance echocardiographic diagnosis. Built in partnership with the NHS and Mayo Clinic, its EchoGo® platform helps clinicians detect complex heart diseases earlier and more accurately—using nothing more than a standard ultrasound
More news about: Ultromics
Dec 15, 2025, 16:54 ET NEUBERGER BERMAN HIGH YIELD STRATEGIES FUND ANNOUNCES CHANGES TO PORTFOLIO MANAGEMENT TEAM
YORK, Dec. 15, 2025 /PRNewswire/ -- Neuberger Berman High Yield Strategies Fund Inc. (NYSE American: NHS) (the "Fund") has announced that Joseph Lind, co-Portfolio Manager to the Fund, will expand his role and become Co-Head of Special Situations effective
More news about: Neuberger Berman
Dec 12, 2025, 06:20 ET Record displacement highlights critical need for clean water to prevent disease, explains Hydrachem
disinfection and sterilisation. Operating in over 60 countries, the company partners with NGOs, governments and leading healthcare institutions, including the NHS, to combat waterborne diseases, maintain hygienic environments and produce over 10 billion litres of safe drinking water each year.Hydrachem
More news about: Hydrachem
Dec 11, 2025, 13:22 ET Wobble Genomics To Present New Data At SABCS Confirming Platform's Ability To Determine Detailed Profiling of HER2 Status in Tissue and Blood
advisors in genomics, diagnostics and oncology. Wobble Genomics is currently conducting clinical studies in partnership with the National Health Service (NHS) in the UK.For more information about Wobble Genomics, please visit wobblegenomics.com.
More news about: Wobble Genomics
Dec 10, 2025, 08:00 ET Trend Micro Honors Global Leaders in Cybersecurity with 2025 Global Customer Awards
us to deliver stronger, more secure outcomes for our customers." Stuart MacLellan, Chief Technology Officer, South London Maudsley NHS Foundation Trust: "It's a real privilege to get recognition for this award from Trend. The team, including those in Trend that work with us, has
More news about: Trend Micro Incorporated
Dec 10, 2025, 07:22 ET Socura officially accredited as a Great Place To Work certified company
Socura, a UK-based cybersecurity services provider that protects many of the nation's biggest NHS trusts, councils, and private companies, has been certified by Great Place To Work®*. The certification follows an independent,
More news about: Socura
Dec 09, 2025, 02:58 ET Four NHS trusts boost collaboration with Sectra's cloud service to deliver improved patient care
Sectra (STO: SECT B) will provide four NHS trusts with a single enterprise imaging solution delivered as a cloud service, Sectra One Cloud. Three of these trusts are existing Sectra customers,
More news about: Sectra
Dec 08, 2025, 07:00 ET Karyopharm to Participate in Baird's Biotech Discovery Series
Wednesday, December 10, 2025 at 12:00 p.m. ET. Dr. Harrison is Professor of Myeloproliferative Neoplasms, Clinical Director at Guy's and St. Thomas' NHS Foundation Trust and a leading international expert in myelofibrosis.A live webcast of the event can be accessed under "Events & Presentations"
More news about: Karyopharm Therapeutics Inc.
Dec 03, 2025, 09:05 ET FMI Reports Strong 11.7% CAGR Growth Outlook for the GLP-1 Receptor Agonist Market Through 2035
demand for GLP-1 therapies.United KingdomWith a mature healthcare ecosystem, the UK continues to expand access through NHS coverage and proactive preventive-care programs.Competitive Landscape: Manufacturers Strengthen Pipelines Amid Global DemandLeading
More news about: Future Market Insights, Inc.
Dec 03, 2025, 09:00 ET Iris® Powered by Generali Recaps 2025 Product Enhancements and Major Industry Recognition
also extended its medical monitoring suite with identifiers including Medical Record Number (MRN), Medicare Beneficiary Identifier (MBI), and the UK NHS number. Social Media Monitoring capabilities were also broadened to support four additional EU languages (Spanish, French, German, and Italian), enabling
More news about: Iris Powered by Generali
Dec 03, 2025, 07:34 ET Virax Biolabs' CEO James Foster Outlines Clinical Progress and 2026 Priorities in Latest Annual Letter to Shareholders
Lyme disease ("PTLD"), and ME/CFS. This multi-site study, involving five clinical centres and run in collaboration with the National Health Service ("NHS"), is designed to generate the clinical data required to support planned regulatory submissions and ultimately to help inform patient care over time.
More news about: Virax BioLabs Group Limited